Trump’s HHS defends Biden-era stance on 340B rebate modelsnews2025-03-17T19:56:43+00:00March 17th, 2025|Endpoints News|
Federal Circuit ruling keeps Amgen’s Eylea biosimilar on the marketnews2025-03-14T19:05:53+00:00March 14th, 2025|Endpoints News|
Why Gilead could lose its HIV product hopping casenews2025-03-12T18:52:24+00:00March 12th, 2025|Endpoints News|
Merck dodges ‘failure to warn’ claims in federal Gardasil casesnews2025-03-11T17:39:19+00:00March 11th, 2025|Endpoints News|
Federal judge denies preliminary injunction in tirzepatide compounding casenews2025-03-10T16:48:58+00:00March 10th, 2025|Endpoints News|
Bayer eyes capital raise as it grapples with Monsanto casesnews2025-03-07T19:41:18+00:00March 7th, 2025|Endpoints News|
Moderna stands by its Covid vaccine patents after PTAB decisionnews2025-03-06T19:52:02+00:00March 6th, 2025|Endpoints News|
Judge grants new nationwide block on NIH payment cuts news2025-03-05T20:52:17+00:00March 5th, 2025|Endpoints News|
Novo Nordisk will join lawsuit over end of semaglutide shortagenews2025-03-05T20:51:49+00:00March 5th, 2025|Endpoints News|
Bhattacharya hearing updates: Trump NIH nominee faces Senatenews2025-03-05T14:00:45+00:00March 5th, 2025|Endpoints News|
